Skip to main content
Curiox Biosystems Co., Ltd. logo

Curiox Biosystems Co., Ltd. — Investor Relations & Filings

Ticker · 445680 ISIN · KR7445680002 KO Manufacturing
Open in API
Filings indexed 130 across all filing types
Latest filing 2024-08-07 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 445680

About Curiox Biosystems Co., Ltd.

https://www.curiox.com/

Curiox Biosystems is a life science technology company that develops and manufactures automated solutions for cell sample preparation. The company specializes in centrifuge-free technologies designed to standardize and improve workflows for cell analysis. Its core C-FREE™ technology utilizes a gentle, laminar flow-based washing method that replaces traditional centrifugation. This approach minimizes cell stress and loss, thereby enhancing cell retention, viability, and the quality of downstream analytical data. Curiox's product portfolio includes the Pluto series of automated liquid handling workstations and associated consumables. These systems automate critical steps such as cell washing, antibody staining, and antibody cocktailing for applications including flow cytometry, single-cell sequencing, and multiplex immunoassays, supporting research with various sensitive cell types.

Recent filings

Filing Released Lang Actions
전환가액의조정 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory filing from a Korean company (Curiox Biosystems) regarding the adjustment of the conversion price of convertible bonds due to a bonus issue (free capital increase). This type of disclosure is a standard corporate action related to capital structure and financing instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate fit as it covers updates on financing activities and capital structure changes, including adjustments to convertible securities.
2024-08-07 Korean
권리락 (무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for Curiox Biosystems. It provides specific details about the stock code, reference price, and the effective date. This falls under the category of capital changes or share issues, which is best classified as SHA (Share Issue/Capital Change).
2024-08-05 Korean
증권발행결과(자율공시) (제1회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the final issuance amount, payment date, and confirms the completion of the financing activity. This falls under the category of capital and financing updates.
2024-07-26 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This document outlines the terms of the financing, including interest rates, conversion prices, put/call options, and the use of proceeds. In the context of Korean corporate filings, this is a standard regulatory disclosure regarding capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2024-07-23 Korean
주권매매거래정지 (무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for 'Curiox Biosystems' due to a bonus issue (무상증자). It cites specific KOSDAQ market regulations and provides the suspension period. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or share buybacks, it falls under the general regulatory filing category.
2024-07-23 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Curiox Biosystems regarding a 'Bonus Issue' (무상증자결정). This involves a change in the company's capital structure through the issuance of new shares to existing shareholders. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2024-07-23 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.